Literature DB >> 35301421

Predicting prolonged length of stay in hospitalized children with respiratory syncytial virus.

Krista Wollny1,2,3, Tona Pitt4, Darren Brenner5,6,7, Amy Metcalfe5,6,8,9.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in children. This study aimed to predict the prolonged length of stay in children admitted to hospital with RSV.
METHODS: Children aged <2 years with RSV in the National Inpatient Sample (NIS) were included in the analyses. The primary outcome was prolonged length of stay (≥90th percentile). Logistic regression models were developed using data from 2016; internal validation was completed using a bootstrapped sample. Data from 2017 were used to validate out-of-sample discrimination and calibration of the models.
RESULTS: The sample included 9589 children; 1054 had prolonged length of stay (≥7 days). Children who were younger, transferred from another hospital, and required intubation during admission had a higher risk of prolonged length of stay. The prediction model included age, transport, intubation, comorbidities, hospital location, and teaching status. The area under the receiver operating characteristic curve was 0.73, demonstrating good predictive ability. The model performed similarly in external validation.
CONCLUSIONS: Variables that predict the prolonged length of stay for RSV include younger age, transport, intubation, comorbidities, hospital location, and teaching status. This can be used to predict children who will have a prolonged length of stay when hospitalized for RSV. IMPACT: There are no recommended treatments for RSV; medical care involves supportive treatment such as oxygen delivery, hydration, and antipyretics. The clinical course is difficult to predict, partially attributable to the supportive nature of care and the sparsity of evidence-based therapies for this population. A prediction model was developed, demonstrating variables that predict prolonged length of stay in RSV hospitalizations, including age, interhospital transport, intubation, comorbidities, hospital location, and teaching status. The model was developed with a sample size of 9589 that is representative of all hospitalizations in the United States.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Year:  2022        PMID: 35301421     DOI: 10.1038/s41390-022-02008-9

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

Review 1.  Respiratory Syncytial Virus Bronchiolitis in Children.

Authors:  Dustin K Smith; Sajeewane Seales; Carol Budzik
Journal:  Am Fam Physician       Date:  2017-01-15       Impact factor: 3.292

2.  Ten years of severe respiratory syncytial virus infections in a tertiary paediatric intensive care unit.

Authors:  Hiep Pham; Jenny Thompson; Danielle Wurzel; Trevor Duke
Journal:  J Paediatr Child Health       Date:  2019-05-16       Impact factor: 1.954

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.